Correlation Between Adimmune Corp and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adimmune Corp and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adimmune Corp and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adimmune Corp and Medigen Vaccine Biologics, you can compare the effects of market volatilities on Adimmune Corp and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adimmune Corp with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adimmune Corp and Medigen Vaccine.

Diversification Opportunities for Adimmune Corp and Medigen Vaccine

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Adimmune and Medigen is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Adimmune Corp and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and Adimmune Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adimmune Corp are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of Adimmune Corp i.e., Adimmune Corp and Medigen Vaccine go up and down completely randomly.

Pair Corralation between Adimmune Corp and Medigen Vaccine

Assuming the 90 days trading horizon Adimmune Corp is expected to generate 2.75 times less return on investment than Medigen Vaccine. In addition to that, Adimmune Corp is 1.02 times more volatile than Medigen Vaccine Biologics. It trades about 0.18 of its total potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about 0.5 per unit of volatility. If you would invest  3,525  in Medigen Vaccine Biologics on November 3, 2024 and sell it today you would earn a total of  1,380  from holding Medigen Vaccine Biologics or generate 39.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Adimmune Corp  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
Adimmune Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adimmune Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

Adimmune Corp and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adimmune Corp and Medigen Vaccine

The main advantage of trading using opposite Adimmune Corp and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adimmune Corp position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind Adimmune Corp and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites